Knee Related Subchondral Bone Lesions Treated With IOBP
Start Date
11/17/2021
Completion Date
5/17/2027
Summary
The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing system to treat subchondral bone pathology (SBP).
Detailed Description
The study will be a prospective, multicenter, clinical study, enrolling both male and female patients. Subjects will be identified among the investigators' patient population scheduled for the IOBP® procedure and as being diagnosed with symptomatic SBP that have failed conservative management. IRB approval will be obtained by each participating institution. The primary outcome measure is adverse event evaluation to determine whether IOBP® can prevent further surgical intervention (i.e., knee replacement surgery, HTO, or calcium phosphate stabilization of SBP) when used to treat symptomatic SBP of the knee.
Eligibility Criteria
Age Range: 18 years to 60 years
Interventions
IntraOsseous BioPlasty® (IOBP®) Surgical Technique into the knee
Conditions
Locations
University of Colorado Sports Medicine
Denver, Colorado 80222
United States
Andrews Research and Education Foundation
Gulf Breeze, Florida 32561
United States
TidalHealth Peninsula Regional, Inc.
Salisbury, Maryland 21801
United States
The Ohio State University
Columbus, Ohio 43201
United States
Allegheny-Singer Research Institute
Pittsburgh, Pennsylvania 15212
United States